Introduction
Invasive cervical cancer is the fourth most common cancer in women and seventh most common cancer in general, with 527.624 new cases and 265.672 deaths in 2012, accounting for 7.5% of all cancer deaths in women [1] . According to the latest data from Global Cancer Observatory, Macedonia has an estimated incidence of cervical cancer of 12.4 per 100,000 inhabitants and it ranks 17 th in Europe, which is close to the European average of 11.4 per 100,000 [2] . Squamous cell carcinoma of the cervix is the most common histological subtype of cervical cancer. About 90% of cervical cancer cases are squamous carcinomas, 10% are adenocarcinomas, and a small number are other types [3] . The occurrence of cervical cancer is preceded by various types of intraepithelial lesions including a series of progressive morphological changes, from productive human papillomavirus (HPV) infection/mild dysplasia to in situ carcinoma [4] . The most common risk factor for squamous cells abnormalities of the uterine cervix is HPV infection, especially with high-risk HPV genotypes. Only persistent, high-risk HPV infection represents a major risk factor for squamous cell abnormalities of the uterine cervix [5] . Deoxyribonucleic acid (DNA) from HPV has been found in 99.7% of cases of cervical carcinoma [6] . There are different classifications of HPV: by genetic similarity, by oncogenic potential and by affinity for certain tissues. According to their oncogenic potential, they are divided into high-risk and lowrisk [7] . The prevalence of HPV genotypes varies by geographical regions. In Europe and North America, HPV-16 is still the most common high-risk genotype [8] . The population of young women, from 18 to 25, has the highest rates of HPV infection. After the age of 25 years, the incidence of HPV infection is reduced to reach its second highest level after the age of 45 years [9] . Detection of HPV can be done using two methods; the first one is direct hybridization or in situ hybridization, and the other is amplification or polymerase chain reaction (PCR) [10] . The aims of the study were to confirm the association between HPV infection and squamous cells abnormalities of the uterine cervix, detection and typing HPV genotypes, which are the most common causes of intraepithelial lesions and cervical cancer, to determine the prevalence of HPV infections and the most affected age groups.
Material and Methods
This cross-sectional study included 128 sexually active women aged 20 to 59 years, with abnormal cervical cytological findings, i.e. a finding of Papanicolaou (PAP) test showing a squamous intraepithelial lesion or invasive squamous cervical cancer.
The study did not include pregnant women, women with previous surgery of the uterine cervix (cervical conization, carbon dioxide laser vaporization and total abdominal hysterectomy) as well as previous abnormal cytological and histopathological findings of the uterine cervix.
The study was conducted in the period from January 2016 to June 2017.
The study was conducted at the University Clinics of Gynecology and Obstetrics and Radiotherapy and Oncology in Skopje, Republic of Macedonia.
All women underwent HPV testing and colposcopic cervical biopsy with endocervical curettage for histopathological analysis.
All samples for cytological analysis were taken using the ThinPrep PAP test and were analyzed in the cytological laboratory at the University Clinic of Gynecology and Obstetrics in Skopje by a cytopathologist. Cytological results were classified according to the revised Bethesda classification [11, 12] including atypical squamous cells of undetermined significance (ASC-US); atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H); low grade squamous intraepithelial lesion (LSIL), cervical intraepithelial neoplasia grade 1 (CIN1); high grade squamous intraepithelial lesion (HSIL), cervical intraepithelial neoplasia grade 2 (CIN2), cervical intraepithelial neoplasia grade 3 (CIN3), carcinoma in situ (CIS) and invasive squamous cell carcinoma.
Samples for histopathological analysis were taken at the University Clinic of Gynecology and Obstetrics in Skopje and were analyzed at the University Clinic of Radiotherapy and Oncology in Skopje, at the Department of Histopathology and Clinical Cytology by an experienced histopathologist. According to the morphology determined in bioptic samples, cervical findings were characterized as normal findings (non-specific cervicitis); LSIL (cervicitis chronica virosa, flat condyloma, mild dysplasia); HSIL (moderate dysplasia, severe dysplasia, in situ squamous cell carcinoma) and invasive squamous cell carcinoma [13] .
Cervical biopsy samples were taken for HPV testing and analyzed at the University Clinic of Gynecology and Obstetrics in Skopje, at the Laboratory for HPV testing. HPV detection and typing were done using multiple polymerase chain reaction (Multiplex PCR) and reverse hybridization. The results of the HPV test were analyzed and demonstrated based on the presence or absence of DNA from HPV and the specified genotype [14] . The first step in HPV testing was the isolation of DNA from the collected cells from cervical biopsies. For isolation of DNA series, three paraffin cuts were prepared. The cuts were incubated in 1 ml xylene for 5 minutes at 55℃ and centrifuged at 10.000 G for 5 minutes at room temperature. The same procedure was repeated two more times. After careful removal of the remains of xylene, the samples were briefly incubated twice in 1 ml of 100% ethanol, and centrifuged for 5 minutes at room temperature. After removal of ethanol and a short air dry, the cuts were incubated overnight in a buffer with freshly added proteinase K at 55℃. The second step was the detection of DNA in HPV by using PCR. To verify the quality and integrity of the isolated DNA, actually of a present inhibitor, a reaction of multiplication of primers for beta globin PC04 and GH20 was first made for each sample. Three pairs of primers were used, common to a larger number of HPV types: degenerate beginners My09/My11 and CPI/CPII G and Gp5/6+. The samples were carried through all reactions with primers specific to high-risk and low-risk HPV genotypes. The third step was genotyping by using reverse hybridization. It is a method that is based on the hybridization of specific DNA probes that are immobilized on nitrocellulose or nylon tapes. It is a set of beginners (SPF 10) with aim-propagation of the L1 gene on the viral DNA. The product of amplification with SPF beginners of 65 bp allows detection of 25 new genotypes. Denatured biotinylated PCR products are hybridized with specific oligonucleotide probes that are immobilized as parallel lines on membrane strips. After hybridization and washing with streptavidin, alkaline phosphatase is added, which binds to the biotinylated hybrids formed previously. Incubation with BCIP (5-bromo-4-chloro-3-indolyl-phosphate)/NBT (nitro blue tetrazolium) chromogens give purple precipitate and the results are interpreted visually. Data analysis was done using the Excel database. Statistical analysis of the established statistical series was done by the statistical package for the social sciences, version 23.0. The structure of numerical signs was analyzed by determining the measures of central tendency (arithmetic mean) and measures of dispersion (standard deviation).
The analysis of the relationship (existence of association) between two sets of attribute variables was performed using the Chi-square test. Statistical significance was defined as p value <0.05.
Results
Of the 128 examined patients, aged 20 to 59 years (40.50 ± 10.85), 28 (21.87%) were aged 20 -29; 38 (29.69%) 30 -39 years; 30 (23.44%) 40 -49 years, and 32 (25.00%) were aged 50 -59 years.
The distribution of HPV infection in 128 patients, correlated with cytopathological diagnosis, is shown in Table 1 .
Data analysis showed an increase of HPV infection with an increase in the cytopathological grade of the cervical lesion. There were 46.15% (6/13) of samples with ASC-US, 57.14% (4/7) with ASC-H, 70.97% (22/31) with LSIL, 80.36% (45/56) with HSIL, and 90.48% (19/21) with invasive squamous cell carcinoma (chi-square test = 10.7682, p = 0.029296, p ˂ 0.05).
Data analysis showed an association between the oncogenic potential of the virus and the cytopathological grade of cervical lesions (chi-square test = 23.8298, p = 0.000086, p ˂ 0.05).
Distribution of HPV infection in 128 patients in correlation with histopathological diagnosis is shown in Table 2 .
HPV infection was detected in 75.00% (96/128) of studied patients. The lowest percentage was observed in LSIL -63.41% (26/41), with an increase to 83.33% (45/54) in HSIL and 87.50% (21/24) in invasive squa- Data analysis showed an association between the HPV infection and the appearance of squamous cell abnormalities of the uterine cervix (chi-square test = 4.8204, p = 0.028125, p < 0.05).
The prevalence of high-risk and low-risk HPV positive tests was 56.25%: 10.94% (i.e. 75.00%: 14.58% among HPV positive patients).
Data analysis showed an increase of high-risk HPV associated with increased histopathological lesions, from 21.95% (9/41) in LSIL, over 77.78% (42/54) in HSIL and up to 83.33% (20/24) in invasive squamous cell carcinoma.
The analysis also showed an association between the oncogenic potential of the virus and the his-topathological grade of cervical lesion (chi-square test = 31.5089, p = 0.00001, p <0.05). The incidence of HPV infection was 85.71% (24/28) in patients aged 20 -29 years; 65.79% (25/38) in 30 -39 years; 73.33% (22/30) in 40 -49 years, and 78.12% (25/32) in patients aged 50 -59 years ( Table 3) .
A single HPV infection was detected in 42.97% (55/128) of all patients (i.e. in 57.29% of HPV positive patients). The most common single HPV infection was high-risk HPV in 53.12% (51/96) ( Table 4) .
Mixed HPV infection was detected in 32.03% (41/128) of all patients (i.e. 42.71% of HPV positive patients). The most common co-infection was high risk with high-risk HPV: 22.45% (22/96). Co-infection with high-risk and low-risk HPV was found in 11.46% (11/96), and co-infection with low-risk and low-risk Dabeski D. HPV Infection and ASC of the Cervix (Table 5) .
HPV typing identified a total of 20 HPV genotypes, of which 15 were high-risk (HPV -16, -18, -31, -33, -35, -39, -45, -52, -53, -56 , -58 -59, -66, -68, and -73) and 5 low-risk (-6, -11, -40, -42 and -61). The prevalence of 20 HPV genotypes in single and mixed HPV infections in correlation with histopathological diagnosis is shown in Table 6 .
Among high-risk HPV genotypes, HPV-16 was the most common (43.75%; 42/96), followed by (in descending order) HPV-31 (15.62%; 15/96), HPV-18 10.4%, 10/96), HPV-45 (9.37%, 9/96), HPV-33 (7.29%, 7/96), HPV-35, -52 and -56 (5.21%; 5/96), etc. Among the low-risk HPV genotypes, the most common was HPV-6 (14.58%; 14/96), followed by HPV-11 (9.37%; 9/96). HPV-16 was most common in patients with HSIL and invasive squamous cell carcinoma, while HPV-6 in patients with LSIL (Table 6 ).
Discussion
In 1976, Harald zur Hausen published his hypothesis about the probable association of cervical cancer Dabeski D. HPV Infection and ASC of the Cervix and intraepithelial lesions with identical cause (HPV), which also causes hyperproliferative changes in the genital tract [15] . In 1996, the World Health Association recognized the importance of HPV for cervical cancer [6] . Early detection and treatment of squamous cell abnormalities of the uterine cervix can be crucial in the prevention of cervical cancer [16] . About 75% of the sexually active population has been in contact with one or more HPV genotypes in the course of their lives [17] . Depending on the geographical region, the study population and the method used, the frequency of HPV genotypes varies considerably in various cervical lesions. In this study, HPV infection was detected in 75% of the examined women. This relatively high percentage of HPV infection in women with squamous cell abnormalities of the uterine cervix corresponds with some previously published studies; in the study of Ma- [22] . In these four studies, the most common HPV genotypes were HPV-16 and HPV-31, but there were discrepancies in the distribution of other most common HPV genotypes. In this study, a significant association was found between the HPV infection and the incidence of squamous intraepithelial lesions and squamous invasive cervical cancer (p = 0.028125). High percentage of high-risk HPV genotypes found in severe dysplasia (73.91%), in in situ squamous cell carcinoma (87.50%) and invasive squamous cell carcinoma (83.33%) once again confirmed a strong relationship between the on-cogenic potential of the virus, the development of squamous intraepithelial lesions, and squamous invasive carcinoma of the cervix (p ˂ 0.00001). The relationship between high-risk and low-risk HPV-genotypes in HPV positive patients was 75.00%:14.58%. In the Spanish study conducted by Garcia-Garcia in 2010, the ratio was 79.80%:19.70% [23] . The high percentage of HPV-16 in severe dysplasia (63.16%), in in situ squamous cell carcinoma (57.14%) and invasive squamous carcinoma (47.62%), distinguishes HPV-16 as a high risk genotype with the highest oncogenic potential. In this study, mixed HPV infection was found in 32.03% of patients, Evans, 2006 , showed the highest prevalence of HPV infection in patients under the age of 30 (96.00%; 458/475) [28] ; the same percentage of HPV infection (96.00%) was also found by Hariri et al., 2012 , in a study that included 3.058 American women aged 18 to 39 [29] . The highest prevalence of mixed HPV infection was detected (58.33%) in the group of patients under 30 years of age. A high prevalence in the young population can be explained by their sexual behavior, that is, promiscuity. A Serbian study by Kovačević G. et al., 2016, including students from the University of Novi Sad found mixed HPV infection in 49.4% [30] . Relatively high rates of mixed HPV infection among the young population were also detected in the Bulgarian studies of Grozdanov P., 2014 (63.00%) [31] and Kovachev S., 2013 (53.00%) [32] , as well as in the Romanian study of Moga M., 2014 (54.93%) [33] .
Conclusion
This study has confirmed that there is an association between human papillomavirus deoxyribonucleic acid infection and atypical cervical squamous cells; the young population under 30 years of age is the most affected, and human papillomavirus-16 is the most common genotype in our environment.
